Esmya for uterine fibroids given the European okay
This article was originally published in Scrip
Executive Summary
Gedeon Richter has announced that the European Commission has granted marketing authorisation for Esmya (ulipristal acetate), for pre-operative treatment of moderate to severe symptoms of uterine fibroids (myomas) in adult women.